Abstract
We have identified three missense mutations in the nucleotide-binding domain (NBD) of CARD15/NOD2 in four French and German families with Blau syndrome. Our findings indicate that, in addition to Crohn disease, CARD15 is involved in the susceptibility to a second granulomatous disorder.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Blau, E.B. J. Pediatr. 107, 689–693 (1985).
Tromp, G. et al. Am. J. Hum. Genet. 59, 1097–1107 (1996).
Ogura, Y. et al. J. Biol. Chem. 276, 21228–21234 (2001).
Hugot, J.P. et al. Nature 411, 599–603 (2001).
Ogura, Y. et al. Nature 411, 603–606 (2001).
Häfner, R. & Vogel, P. Clin. Exp. Rheumatol. 11, 685–691 (1993).
Manouvrier-Hanu, S. et al. Am. J. Med. Genet. 76, 217–221 (1998).
Inohara, N. et al. J. Biol. Chem. 276, 2551–2554 (2001).
Miller, J.J. J. Pediatr. 109, 387–388 (1986).
Acknowledgements
We thank the patients and their families who participated in this study. We acknowledge P. Pasturaud, C. Vaury, T.H. Bui, F. Merlin and M. Legrand for technical assistance. We thank L. Pascoe for critically reading the manuscript. This work was supported by the Association de recherche sur les polyarthrites (ARP).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miceli-Richard, C., Lesage, S., Rybojad, M. et al. CARD15 mutations in Blau syndrome. Nat Genet 29, 19–20 (2001). https://doi.org/10.1038/ng720
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng720
This article is cited by
-
A probiotic bi-functional peptidoglycan hydrolase sheds NOD2 ligands to regulate gut homeostasis in female mice
Nature Communications (2023)
-
Incomplete penetrance of NOD2 C483W mutation underlining Blau syndrome
Pediatric Rheumatology (2022)
-
Monogenic disorders as mimics of juvenile idiopathic arthritis
Pediatric Rheumatology (2022)
-
A novel mutation in early‐onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes
Pediatric Rheumatology (2021)
-
Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients
Pediatric Rheumatology (2021)